Y-mAbs Therapeutics, Inc. Quarterly Other Liabilities, Noncurrent in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Y-mAbs Therapeutics, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2018 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2024 was $897K, a 9.12% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $897K +$75K +9.12% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $847K +$31K +3.8% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $853K +$36K +4.41% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $864K +$62K +7.73% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $822K +$89K +12.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $816K +$36K +4.62% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $817K -$18K -2.16% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $802K -$49K -5.76% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $733K -$138K -15.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $780K -$159K -16.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $835K -$1.1M -56.8% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $851K -$1.12M -56.8% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $871K -$1.05M -54.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $939K -$790K -45.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.93M +$1.48M +323% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.97M +$1.73M +713% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.92M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.73M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $457K Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $242K +$18K +8.04% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $224K Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.